Association of blood pressure and genetic background with white matter lesions in patients with mild cognitive impairment.
暂无分享,去创建一个
Cristina Geroldi | Giuliano Binetti | Samantha Galluzzi | Matteo Bonetti | Luisa Benussi | Roberta Ghidoni | Giovanni B Frisoni | Dario Manfellotto | G. Frisoni | C. Testa | S. Galluzzi | R. Zulli | C. Geroldi | G. Binetti | L. Benussi | R. Ghidoni | M. Bonetti | G. Romanelli | Giuseppe Romanelli | Roberto Zulli | D. Manfellotto | Cristina Testa | Genoveffa Borsci | Genoveffa Borsci
[1] I. Akiguchi,et al. The Relationship between 24-Hour Blood Pressure Readings, Subcortical Ischemic Lesions and Vascular Dementia , 2005, Cerebrovascular Diseases.
[2] Leonardo Pantoni,et al. Pathophysiology of Age-Related Cerebral White Matter Changes , 2002, Cerebrovascular Diseases.
[3] D. Sander,et al. Changes of circadian blood pressure patterns are associated with the occurence of lucunar infarction. , 1998, Archives of neurology.
[4] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[5] M. Hori,et al. Relations of Serum High-Sensitivity C-Reactive Protein and Interleukin-6 Levels With Silent Brain Infarction , 2005, Stroke.
[6] G. Parati,et al. Blood pressure variability and silent cerebral damage in essential hypertension. , 2004, American journal of hypertension.
[7] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[8] B T Hyman,et al. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. , 2000, Archives of neurology.
[9] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[10] A Hofman,et al. C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.
[11] A Hofman,et al. Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.
[12] B L Miller,et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.
[13] Roger M. Nitsch,et al. Alzheimer disease-associated cystatin C variant undergoes impaired secretion , 2003, Neurobiology of Disease.
[14] Christian Enzinger,et al. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study , 2003, The Lancet.
[15] B. Dubois,et al. Clinical spectrum of CADASIL: a study of 7 families , 1995, The Lancet.
[16] L. Fried,et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. , 1998, Stroke.
[17] D. Mann,et al. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[18] Thomas E. Nichols,et al. Lesion probability maps of white matter hyperintensities in elderly individuals , 2006, Journal of Neurology.
[19] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[20] K. Shulman. Clock‐drawing: is it the ideal cognitive screening test? , 2000, International journal of geriatric psychiatry.
[21] H S Markus,et al. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[22] H. Braak,et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. , 2003, Archives of neurology.
[23] R. Roos,et al. Clinical aspects of cerebral amyloid angiopathy. , 1994, Dementia.
[24] G. Frisoni,et al. Clinical and Neuropsychological Features Associated with Structural Imaging Patterns in Patients with Mild Cognitive Impairment , 2007, Dementia and Geriatric Cognitive Disorders.
[25] A. de la Sierra,et al. Silent cerebral white matter lesions in middle-aged essential hypertensive patients , 2002, Journal of hypertension.
[26] F. Barkhof,et al. Alzheimer’s disease—one clinical syndrome, two radiological expressions: a study on blood pressure , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[27] M. Dichgans. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Phenotypic and mutational spectrum , 2002, Journal of the Neurological Sciences.
[28] M. Jaskólski,et al. The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models , 2006, Brain pathology.
[29] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[30] J. Jolles,et al. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension , 2006, Journal of Human Hypertension.
[31] G. Mancia,et al. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. , 2002, Archives of internal medicine.
[32] V. Mok,et al. Apolipoprotein E ɛ4 allele is associated with the volume of white matter changes in patients with lacunar infarcts , 2006 .
[33] A. Hofman,et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.
[34] R. Roos,et al. Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.
[35] B. Conrad,et al. Extent of cerebral white matter lesions is related to changes of circadian blood pressure rhythmicity. , 2000, Archives of neurology.
[36] Michael F O'Rourke,et al. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.
[37] F. Mee,et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society , 2000, BMJ : British Medical Journal.
[38] Claudio Del Percio,et al. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: A multicentric study , 2006, NeuroImage.
[39] R. Doody,et al. Does APO ε4 correlate with MRI changes in Alzheimer's disease? , 2000 .
[40] F. Fazekas,et al. Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.
[41] G. Frisoni,et al. Mild cognitive impairment with subcortical vascular features , 2002, Journal of Neurology.